Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    • News

  • Stakk Secures T-Mobile Contract to Power Super App Expansion
    Stakk Secures T-Mobile Contract to Power Super App Expansion
    • News

  • Medibank Backs Emyria with Landmark Depression Care Deal
    Medibank Backs Emyria with Landmark Depression Care Deal
    • News

  • NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    • News

  • BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    • News

  • Harris Technology eyes profitability as refurbished tech sales surge
    Harris Technology eyes profitability as refurbished tech sales surge
    • News

  • QIC Fund Backs Ark Mines with $4.5m to Accelerate Sandy Mitchell Development
    • News

  • Swift Secures $2.4m Chevron Contract to Extend Entertainment and Support Services
    Swift Secures $2.4m Chevron Contract to Extend Entertainment and Support Services
    • News

  • FBR’s tech could help reduce housing construction-related cost pressures
    FBR’s tech could help reduce housing construction-related cost pressures
    • News

  • Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    • News

Yearling sales up 28% as Aussie investment surges following Apiam’s equine expansion

  • In News
  • January 25, 2022
  • Alfred Chan
Yearling sales up 28% as Aussie investment surges following Apiam’s equine expansion

Australians are well known to love a punt on the horses but a rising number of Australians are getting involved in racehorse ownership which resulted in a 28% increase in yearling sale prices at this month’s Magic Millions sale on the Gold Coast.

With 776 yearlings changing hands, Australian opened their wallets with aplomb for a chance to own the next champion of the turf with a median sale price of $230,000 per yearling for the sale. Staggeringly, this was a 28% increase on last year’s median sale price at the Gold Coast sale.

Driving this investment in bloodstock is the continued increase in prize money on offer to race horses in Australia.

In FY21, Australians racing horses in New South Wales won $310 million while those who chose to in Victoria were returned $237 million. In Queensland, owner returns totalled $271 million however this included prize money from greyhound racing and harness racing as well under the State’s centralised administration.

Over the past 10 years, the prize money on offer in Australian Thoroughbred racing has increased 82% with a total of $879.6 million returned to owners in 2021 across the country.

Rising investment in Australia’s racing industry continues to be the lifeblood of many regional towns across the Eastern seaboard. According to Racing Australia’s 2021 Fact Book, the industry had 11,898 registered employees last year, but that figure increases significantly when you add periphery services such as vets, transport operators, and feed suppliers.

Given the continued increases in prize money on offer from Thoroughbred racing, the demand to race horses flows down through the breeding industry as evidenced by the 28% increase in the Magic Millions median sale price for yearlings.

Having identified this growing demand, Australia’s largest operator of regional vet clinics Apiam Animal Health (ASX: AHX) has been actively expanding its footprint to service the racing, breeding and performance horse industries.

The operator has long had a large presence in the production and companion animal sectors but last year made one of their single largest acquisitions when acquiring Scenic Rim Vets in Queensland for $16m in June 2021, right at the start of the breeding season. Subsequently, many of the yearlings that will be going through future Magic Millions sales will have been examined and in some cases treated by Scenic Rim vets which is just one of Apiam’s dedicated equine hubs.

With its 13 veterinarians and further support staff, Scenic Rim is one of the largest equine service providers in Queensland, located in the heart of the State’s breeding industry.

Following the success witnessed from Scenic Rim while operated under Apiam’s hub-and-spoke model, the Company went on to acquire Agnes Banks Equine Clinic in November 2021, a clinic that employs 14 equine vets, of which 3 are registered specialists in Equine Surgery and Medicine.

Similar to their model in Queensland, acquiring Agnes Banks enables Apiam to centralise its equine operations where its feeder clinics around New South Wales can refer business to Agnes Banks while also providing the network with access to those registered equine specialists.

Despite Apiam having been opening their wallets to grow their vertically integrated network of clinics over the past 12 months, Managing Director, Dr Chris Richards believes there are still greater opportunities on the horizon.

“Having already seen encouraging results from the integration of Scenic Rim and Agnes Banks into the Apiam network, we are open to similar equine hubs in other racing-centric regions around Australia,” said Dr Richards.

“We’d had good interest from a few clinics interested in joining the Apiam network where the centralised model greatly assists clinics to capitalise on the growth opportunities, and vets in improving work-life balance. We’ve got a nice pipeline of potential acquisitions to explore in the future.”

The work-life balance mentioned by Dr Richards is in reference to the people-focused initiatives that Apiam is spearheading in the veterinary industry which has proven popular amongst veterinarians.

Emerging as an employer of choice in the animal health industry, their strong focus on people has seen Apiam expand substantially over the past 9 months, taking their national headcount to over 850 staff across 70 locations. With all of these new clinics having joined their network, Apiam has acquired $24.54m in revenue which can be added to the $126.2m generated in FY21 by the Company on a pro forma basis.

While the 28% increase in yearling sale prices was a significant boost, reflecting the increased investment Australians are spending on horses, more could still come across the yearling sale season with further prize money increases expected to be announced by Racing NSW in the coming months.

Such an announcement would follow the $16m boost announced by Racing Victoria in June 2021. As a turf war between the two States is playing out while they fight to lure owners to race in their respective States, service providers like Apiam are well positioned with a large presence across Queensland, New South Wales and Victoria’s racing industry.

Apiam Animal Health welcomes investors to register for updates on their latest developments and industry research by joining their mailing list here.

  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
*Owners of this website are shareholders in a company mentioned in this article and have been engaged by them to assist in investor communications
  •  
  •  
  •  
  •  
  • AHX
  • Apiam Animal Health
  • ASX: AHX
  • bloodstock
  • magic millions
  • Racing Victoria
  • yearling sales
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.